Beyond showing a good correlation with CSF values, serum NfL has already thoroughly been investigated in MS [18], i.e., it has been shown to correlate with clinical and radiological disease activity (relapses, new/enlarged T2 lesions and gadolinium-enhancing lesions in magnetic resonance imaging (MRI)) [19,20,21,22]. Here, NEFL is linked to myeloid sarcoma.